169 related articles for article (PubMed ID: 21131268)
1. Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia.
Frankel PS; Hoonakker AJ; Alburges ME; McDougall JW; McFadden LM; Fleckenstein AE; Hanson GR
J Pharmacol Exp Ther; 2011 Mar; 336(3):809-15. PubMed ID: 21131268
[TBL] [Abstract][Full Text] [Related]
2. Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.
Hanson GR; Hoonakker AJ; Robson CM; McFadden LM; Frankel PS; Alburges ME
J Pharmacol Exp Ther; 2013 Aug; 346(2):173-81. PubMed ID: 23685547
[TBL] [Abstract][Full Text] [Related]
3. Response of limbic neurotensin systems to methamphetamine self-administration.
Hanson GR; Hoonakker AJ; Alburges ME; McFadden LM; Robson CM; Frankel PS
Neuroscience; 2012 Feb; 203():99-107. PubMed ID: 22245499
[TBL] [Abstract][Full Text] [Related]
4. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Psychopharmacology (Berl); 2014 Aug; 231(15):2933-40. PubMed ID: 24522333
[TBL] [Abstract][Full Text] [Related]
5. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
6. Mephedrone alters basal ganglia and limbic neurotensin systems.
German CL; Hoonakker AH; Fleckenstein AE; Hanson GR
J Neurochem; 2014 Aug; 130(3):402-7. PubMed ID: 24678634
[TBL] [Abstract][Full Text] [Related]
7. Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Synapse; 2015 Aug; 69(8):396-404. PubMed ID: 25963809
[TBL] [Abstract][Full Text] [Related]
8. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
Chapman DE; Hanson GR; Kesner RP; Keefe KA
J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR
J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925
[TBL] [Abstract][Full Text] [Related]
10. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
11. Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation.
Sharpe AL; Varela E; Beckstead MJ
PLoS One; 2017; 12(7):e0180710. PubMed ID: 28686721
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
[TBL] [Abstract][Full Text] [Related]
13. Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia.
Antonelli T; Tomasini MC; Fuxe K; Agnati LF; Tanganelli S; Ferraro L
J Neural Transm (Vienna); 2007 Jan; 114(1):105-13. PubMed ID: 16983483
[TBL] [Abstract][Full Text] [Related]
14. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
15. Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity.
Wagstaff JD; Bush LG; Gibb JW; Hanson GR
Brain Res; 1994 Dec; 665(2):237-44. PubMed ID: 7895059
[TBL] [Abstract][Full Text] [Related]
16. CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat.
Krasnova IN; Chiflikyan M; Justinova Z; McCoy MT; Ladenheim B; Jayanthi S; Quintero C; Brannock C; Barnes C; Adair JE; Lehrmann E; Kobeissy FH; Gold MS; Becker KG; Goldberg SR; Cadet JL
Neurobiol Dis; 2013 Oct; 58():132-43. PubMed ID: 23726845
[TBL] [Abstract][Full Text] [Related]
17. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
[TBL] [Abstract][Full Text] [Related]
18. Differential neurotensin responses to low and high doses of methamphetamine in the terminal regions of striatal efferents.
Frankel PS; Hoonakker AJ; Hanson GR; Bush L; Keefe KA; Alburges ME
Eur J Pharmacol; 2005 Oct; 522(1-3):47-54. PubMed ID: 16199030
[TBL] [Abstract][Full Text] [Related]
19. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.
Mark KA; Soghomonian JJ; Yamamoto BK
J Neurosci; 2004 Dec; 24(50):11449-56. PubMed ID: 15601951
[TBL] [Abstract][Full Text] [Related]
20. Distinct responses of basal ganglia substance P systems to low and high doses of methamphetamine.
Hanson GR; Bush L; Keefe KA; Alburges ME
J Neurochem; 2002 Sep; 82(5):1171-8. PubMed ID: 12358764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
